In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1855 News Items found
Kelly Spill is seen outdoors holding her newborn and talking with Dr. Andrea Cercek of Memorial Sloan Kettering Cancer Center.
The Rectal Cancer Clinical Trial at MSK That Changed Everything for Its Patients

Learn how a heralded clinical trial that made rectal cancer disappear for every participant is being expanded at Memorial Sloan Kettering Cancer Center. The trial uses only immunotherapy that targets a rare mutation — without the need for surgery, chemotherapy, or radiation.
Chi Nguyen
2023 GSK Chairman’s Prize Recognizes Chi Nguyen, Research on Gut Health

The 2023 GSK Chairman’s Prize recognizes Chi Nguyen for research on gut health.
An MSK research notebook on a bench in a lab
MSK Research Highlights, August 10, 2023

New MSK research finds a potential target against neuroendocrine transformation in lung and prostate cancers; discovers new clues about why donor T cells attack certain tissues in graft-versus-host disease; sheds light on why T cells let go of their prey; and uses CRISPR interference and dynamic cell-state transitions to discover enhancers that affect early human development.
First-time blood donor
Giving Blood to Help People With Cancer: Tips from a First-Time Donor

Discover how easy it is to donate blood — and the real impact your donation makes.
Drs. Danielle Rochlin and Babek Mehrara
MSK Research Aims to Better Predict and Prevent Lymphedema After Breast Cancer Surgery

Doctors and nurses with Memorial Sloan Kettering’s Plastic and Reconstructive Surgical Service have developed new, simplified models to better predict and prevent breast cancer-related lymphedema.
MSK scientist Britta Weigelt and MSK physician-scientist Sarah Kim
New Progress Using Liquid Biopsies to Analyze cfDNA for Endometrial and Cervical Cancers

Learn how MSK’s liquid biopsy test, MSK-ACCESS, could improve the lives of patients with gynecologic cancers.
Through-the-microscope view of a tissue sample
MSK Research Highlights, July 17, 2023

New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers; developed a new method to enable imaging of two PET tracers simultaneously; found biomarkers that could help predict outcomes in HER2-positive metastatic esophagogastric cancer; and made progress toward improving options for patients with early-stage, potentially indolent cancers.
Once a patient, Jillian is now a breast cancer care coordinator. She shares a love story, a viral video and a special connection to the people of MSK Monmouth.
It’s Personal for Jillian Allegretti, of MSK Monmouth

Once a patient, Jillian is now a breast cancer care coordinator. She shares a love story, a viral video and a special connection to the people of MSK Monmouth.
Selwyn M. Vickers, MD, FACS
A Message From MSK’s President and CEO, Dr. Selwyn Vickers

In cancer care, firsts make a difference. At MSK, we are constantly improving how we help people with those important firsts. Dr. Selwyn Vickers writes about the latest developments at MSK and the encouraging evidence that we are making progress in our mission of ending cancer for life.
Michael Berger, PhD, Co-Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology and Elizabeth and Felix Rohatyn Chair for Junior Faculty
Exposing a Cancer Cell’s Weakness

MSK has developed an arsenal of tests that are at the front lines of precision treatments. They target the structure of proteins that cause cancer, offering people new hope.